... multienzyme 多酶 multikinase 多重激酶 multimerin 多聚蛋白 ...
基于10个网页-相关网页
·2,447,543篇论文数据，部分数据来源于NoteExpress
Sorafenib is an oral multikinase inhibitor with activity against tyrosine kinase receptors that are responsible for blood vessel development and has shown to be active in treating advanced RCC.
索拉非尼是口服的多激酶抑制剂，可以抑制酪氨酸激酶受体，后者促进血管生成并在肾细胞癌中显示出高活性。
youdao
应用推荐
模块上移
模块下移
不移动